LekoskopLekoskop
HR · ES · FR · CS · IT · NL · CH · UK · PL

Novi lijekovi (EU) — Hrvatska

Ukinuta odobrenja, povlačenje serija lijekova, pisma zdravstvenim radnicima i novi lijekovi EU — svakodnevno, automatski. Zadnje ažuriranje: 16. 11. 2026. 08:55

Sve Ukinuta odobrenja8 Povlačenje serija Novi lijekovi (EU)2 Sigurnost (DHPC)1 Europska unija45

Izvori: promjene pratimo na temelju informacija Agencije za lijekove i medicinske proizvode (HALMED) — rješenja o ukidanju odobrenja, obavijesti o povlačenju serija i pisma zdravstvenim radnicima. Odluke o centralizirano odobrenim lijekovima dolaze iz registra Unije Europske komisije (oznaka EU). Nestašice i liste lijekova HZZO-a ovdje (još) nisu uključene.

12. 2. 2025.srijeda, 12. veljače 2025.

otvori dan ◀ ▶ 8 događaja
Novo odobrenje EU EU Zefylti
br. EU/1/24/1899 · Zefylti is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia… · CuraTeQ Biologics (Malta) Limited · Filgrastim · ATC L03AA02
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Xbryk
br. EU/1/24/1889 · Prevention of skeletal related events (pathological fracture, radiation to bone, spinal cord compression or su… · Samsung Bioepis NL B.V. · denosumab · ATC M05BX04
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU WELIREG
br. EU/1/24/1893 · <u>Renal cell carcinoma (RCC)</u> WELIREG is indicated as monotherapy for the treatment of adult patients… · Merck Sharp & Dohme B.V. · belzutifan · ATC L01XX74
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Obodence
br. EU/1/24/1890 · Treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. In postmenopausal… · Samsung Bioepis NL B.V. · Denosumab · ATC M05BX04
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Nemluvio
br. EU/1/24/1901 · Atopic dermatitis (AD) Nemluvio is indicated for the treatment of moderate-to-severe atopic dermatitis in p… · Galderma International · Nemolizumab · ATC D11AH12
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Kostaive
br. EU/1/24/1873 · Kostaive is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 years… · Seqirus Netherlands B.V. · zapomeran · ATC J07BX03
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Eydenzelt
br. EU/1/24/1895 · Eydenzelt is indicated for adults for the treatment of • neovascular (wet) age-related macular degeneration (… · Celltrion Healthcare Hungary Kft. · Aflibercept · ATC S01LA05
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Emcitate
br. EU/1/24/1897 · Emcitate is indicated for the treatment of peripheral thyrotoxicosis in patients with monocarboxylate transpor… · Rare Thyroid Therapeutics International AB · Tiratricol · ATC H03AA04
Što to znači, detalji

Učitavanje…

10. 2. 2025.ponedjeljak, 10. veljače 2025.

otvori dan ◀ ▶ 3 događaja
Novo odobrenje EU EU Korjuny
br. EU/1/24/1826 · Korjuny is indicated for the intraperitoneal treatment of malignant ascites in adults with epithelial cellular… · Atnahs Pharma Netherlands B. V. · catumaxomab · ATC L01FX03
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU BEYONTTRA
br. EU/1/24/1906 · BEYONTTRA is indicated for the treatment of wild-type or variant transthyretin amyloidosis in adult patients w… · Bayer AG · acoramidis · ATC C01EB25
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU ANDEMBRY
br. EU/1/24/1885 · Andembry is indicated for routine prevention of recurrent attacks of hereditary angioedema (HAE) in adult and … · CSL Behring GmbH · garadacimab · ATC B06AC07
Što to znači, detalji

Učitavanje…

3. 2. 2025.ponedjeljak, 3. veljače 2025.

otvori dan ◀ ▶ 1 događaj
Novo odobrenje EU EU HETRONIFLY
br. EU/1/24/1870 · Small cell lung cancer (SCLC) HETRONIFLY in combination with carboplatin and etoposide is indicated for the… · Accord Healthcare S.L.U. · serplulimab · ATC L01FF12
Što to znači, detalji

Učitavanje…

20. 1. 2025.ponedjeljak, 20. siječnja 2025.

otvori dan ◀ ▶ 2 događaja
Novo odobrenje EU EU Lazcluze
br. EU/1/24/1886 · Lazcluze in combination with amivantamab is indicated for the first line treatment of adult patients with adva… · Janssen-Cilag International NV · lazertinib · ATC L01EB09
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU KAVIGALE
br. EU/1/24/1900 · KAVIGALE is indicated for the pre exposure prophylaxis of COVID 19 in adults and adolescents 12 years of age a… · AstraZeneca AB · Sipavibart · ATC J06BD09
Što to znači, detalji

Učitavanje…

13. 1. 2025.ponedjeljak, 13. siječnja 2025.

otvori dan ◀ ▶ 5 događaja
Novo odobrenje EU EU SIILTIBCY
br. EU/1/24/1882 · SIILTIBCY is indicated as a diagnostic aid for detection of Mycobacterium tuberculosis infection, including di… · Serum Life Science Europe GmbH · rdESAT-6 and rCFP-10 · ATC Pending
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Gohibic
br. EU/1/24/1884 · Gohibic is indicated for the treatment of adult patients with SARS CoV2 induced acute respiratory distress syn… · InflaRx GmbH · vilobelimab · ATC L04AJ10
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Baiama
br. EU/1/24/1887 · Baiama is indicated for adults for the treatment of • neovascular (wet) age-related macular degeneration (AMD… · Formycon AG · Aflibercept · ATC S01LA05
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU Ahzantive
br. EU/1/24/1888 · Ahzantive is indicated for adults for the treatment of: • neovascular (wet) age-related macular degeneration … · Formycon AG · Aflibercept · ATC S01LA05
Što to znači, detalji

Učitavanje…

Novo odobrenje EU EU AUGTYRO
br. EU/1/24/1883 · AUGTYRO as monotherapy is indicated for the treatment of adult patients with ROS1-positive advanced non-small … · Bristol Myers Squibb Pharma EEIG · repotrectinib · ATC L01EX28
Što to znači, detalji

Učitavanje…

Ukupno 274 događaja u ovoj kategoriji.